Covalon Technologies Ltd. (COV)

United States

closing in 1h 27m

005930 232,500.00 5.44%
0700 474.20 1.37%
2330 2,275.00 6.56%
ASML 1,187.40 -2.86%
AZN 13,512.00 -3.13%
ETH/USD 2,363.85 1.77%
EUR/USD 1.17 -0.35%
MC 444.95 -1.43%
NESN 78.05 -1.27%
USD/JPY 157.24 0.23%
XPT/USD 1,003.20 0.33%

005930 232,500.00 5.44%
0700 474.20 1.37%
2330 2,275.00 6.56%
ASML 1,187.40 -2.86%
AZN 13,512.00 -3.13%
ETH/USD 2,363.85 1.77%
EUR/USD 1.17 -0.35%
MC 444.95 -1.43%
NESN 78.05 -1.27%
USD/JPY 157.24 0.23%
XPT/USD 1,003.20 0.33%

005930 232,500.00 5.44%
0700 474.20 1.37%
2330 2,275.00 6.56%
ASML 1,187.40 -2.86%
AZN 13,512.00 -3.13%
ETH/USD 2,363.85 1.77%
EUR/USD 1.17 -0.35%
MC 444.95 -1.43%
NESN 78.05 -1.27%
USD/JPY 157.24 0.23%
XPT/USD 1,003.20 0.33%

005930 232,500.00 5.44%
0700 474.20 1.37%
2330 2,275.00 6.56%
ASML 1,187.40 -2.86%
AZN 13,512.00 -3.13%
ETH/USD 2,363.85 1.77%
EUR/USD 1.17 -0.35%
MC 444.95 -1.43%
NESN 78.05 -1.27%
USD/JPY 157.24 0.23%
XPT/USD 1,003.20 0.33%

1.98000 CAD

0.18

10%

Last update Apr 20, 12:38 PM EDT

Main market

Day range

1.98000

1.99000

Previous close

1.80000

Open

1.99000

Access this stock data via API

Covalon Technologies Ltd.

1.98

0.18

10%

Overview

Access /time_series data via our API — starting from the Basic plan and above.

Description

Covalon Technologies Ltd. is a medical technology company that focuses on developing and commercializing innovative therapeutic solutions for the healthcare industry. The company specializes in advanced wound care, infection prevention, and medical device coatings. Its products are designed to address critical health challenges in hospital and homecare settings, contributing to better patient outcomes and healthcare efficiencies. Covalon Technologies Ltd. is recognized for its proprietary hydrocolloid and antimicrobial silicone technology, which provides enhanced product efficacy. Operating globally, the company serves various sectors within the healthcare market, including hospitals, clinics, and long-term care facilities. Covalon's innovation-driven approach aids in tackling common medical issues such as wound management and infection control, thereby playing a significant role in enhancing patient care and safety across multiple healthcare landscapes. Headquartered in Mississauga, Ontario, Canada, Covalon Technologies Ltd. continues to expand its impact in the medical device field through strategic collaborations and continuous research and development efforts.

About

CEO

Mr. Brent Ashton

Employees

—

Address

1660 Tech Avenue
Unit 5
Mississauga, L4W 5S7, ON
Canada

Phone

905-568-8400

Website

covalon.com

Instrument type

Common stock

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Canada

MIC code

NEOE

Access /profile data via our API — starting from the Grow plan (individual) and the Venture plan (business) and above.

Latest press releases

Nov 14, 2025

Cohen & Steers Announces Changes to Realty Indexes

NEW YORK, Nov. 14, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio Index (IRP), effective as of the close of business on November 21, 2025.

Cohen & Steers Global Realty Majors Portfolio Index (GRM)
Added component (symbol)	Removed component (symbol)
Swiss Prime Site AG (SPSN.SW)	Covivio SA (COV.FP)

Cohen & Steers International Realty Majors Portfolio Index (IRP)
Added component (symbol)	Removed component (symbol)
Swiss Prime Site AG (SPSN.SW)	Covivio SA (COV.FP)

These free-float adjusted, modified market capitalization-weighted total return indexes of selected real estate equity securities are quoted intraday on a real-time basis by the Chicago Mercantile Exchange. The Indexes' modified capitalization-weighted approach and qualitative screening process emphasize companies that Cohen & Steers believes are leading the securitization of real estate globally.

The Indexes can be used as indexing benchmarks, stock selection universes, underlying indexes for derivative instruments or performance benchmarks. All index weightings are independently calculated by Standard & Poor's.

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.

Website: https://www.cohenandsteers.com/

Symbol: (NYSE: CNS)

View original content:https://www.prnewswire.com/news-releases/cohen--steers-announces-changes-to-realty-indexes-302616002.html